Home
HomeChat
Markets
AlertsCalendarScreenerCharts
Portfolio
WatchlistsPortfolioFiles
Account
Docs
Sign upJoinLog inLogin

Profusa, Inc. (PFSA) stock profile

A digital-health company developing tissue-integrating biosensors (e.g. the Lumee™ Oxygen Platform) to continuously monitor body chemistry and provide AI-powered health insights, targeting chronic conditions such as diabetes and critical limb ischemia.

Key facts

SymbolPFSA
ExchangeNASDAQ
SectorHealthcare
IndustryMedical - Equipment & Services
CEOBen Chung-Bin Hwang
Employees2
HeadquartersEmeryVille, CA, US
IPO2025-07-14
Websiteprofusa.com

Explore PFSA on Vantafin

  • Profusa, Inc. Overview
  • Profusa, Inc. Financials
  • Profusa, Inc. News
  • Profusa, Inc. Events
  • Profusa, Inc. SEC filings
  • Profusa, Inc. Insider transactions

Frequently asked questions

What does Profusa, Inc. (PFSA) do?
A digital-health company developing tissue-integrating biosensors (e.g. the Lumee™ Oxygen Platform) to continuously monitor body chemistry and provide AI-powered health insights, targeting chronic conditions such as diabetes and critical limb ischemia.
Where is PFSA stock listed?
Profusa, Inc. trades under the ticker PFSA on NASDAQ.
How can I research PFSA's financials and filings?
Vantafin provides Profusa, Inc.'s income statement, balance sheet and cash-flow data, SEC filings, earnings-call transcripts, and insider & institutional ownership on the PFSA profile.